ArticleFrontiers in oncology2022

Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.

Feng-Lin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.